Searched for
MONOCLONAL ANTI BODIES
Piramal Pharma invests Rs 102 crore in Yapan Bio for significant minority stakeBiologics capabilities can be synergistic with the company's anti-body drug conjugation capabilities; specifically, for customers who prefe...- Glenmark's subsidiary Ichnos Sciences enters pact with Almirall for novel drug to treat autoimmune diseasesUnder the agreement, Almirall is granted global rights to develop and commercialize this monoclonal antibody for autoimmune diseases. Ichno...
- France approves antibody therapy for high-risk Covid casesThe independent public health body HAS Friday night announced "a greenlight for the preventive use of Evusheld... for patients with a very ...
- Maharashtra company starts human trials of drug aimed at mild, moderate cases of COVID-19World's largest vaccine maker Serum Institute of India is the sponsor of the Pune-headquartered iSERA Biological Pvt Ltd's drug project, wh...
- Zydus Cadila, first Indian Company gets permission for clinical trials of antibodies cocktail to treat COVID-19: SourcesThe only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatm...
- 65 yr old man becomes 1st Covid patient to get antibody cocktail at Apollo in DelhiAs part of this single dose infusion-based treatment, patients with mild to moderate symptoms, are offered a cocktail of Casirivimab and Im...
- Coronavirus vaccine will be equally effective against new mutant of coronavirus: CSIR DGThe CSIR's Institute of Genomics and Integrative Biology (IGIB), Delhi and Centre for Cellular and Molecular Biology (CCMB), Hyderabad have...
- US FDA grants emergency use authorization to Regeneron COVID-19 antibody given to TrumpThe FDA said the monoclonal antibodies, casirivimab and imdevimab, should be administered together for the treatment of mild to moderate CO...
- Gilead questions WHO study that cast doubts on drug's COVID-19 benefitsIn a blow to one of the few drugs being used to treat people with COVID-19, the WHO said on Thursday its "Solidarity" trial had concluded t...
- WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patientsThe study found the regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital course among patient...
- Early Covid-19 treatments could be ‘bridge’ to vaccine: Anthony Fauci“We are focusing very heavily now on the treatment of early infection and, or prevention of infection,” Fauci told the Journal of the Ameri...
- UK trials new antibody cocktail treatment for COVID-19As part of the government-backed Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trials, monoclonal antibodies, or potent laboratory-m...
- New discovery: Antibody that may protect against COVID-19 infection identifiedThe researchers from the University of Massachusetts Medical School (UMMS) in the US discovered and characterised a cross-reactive human mo...
- Bharat Bio leads CSIR project to develop human antibodiesThis programme brings together academia — National Centre for Cell Science, Indian Institute of Technology, Indore, and industry – PredOmix...
- Glenmark Pharma releases investigational skin findingsGlenmark Pharma President and Chief Medical Officer Fred Grossman said atopic dermatitis can have a severe impact on quality of life and th...
- Pune firm set to roll out cure for dengueSerum Institute will develop a drug to treat all 4 strains of dengue, and is in the process of applying for a 'speedy approval' to roll-out...
- Glenmark opens new manufacturing facility in SwitzerlandGlenmark Pharmaceuticals opened a new manufacturing facility in Switzerland for supply of clinical trial material.
- Budget 2012: Eliminate 30% duty on imported equipments for a period of 5-10 years, says FICCIFICCI in its pre-budget memorandum has given the following recommendations for the Biotechnology industry
- Rel Life Sciences to focus on R&D, for nowThe company is all set to launch fifth biosimilar drug and seeks approvals for clinical trials and stem-cell treatment.
- Glenmark Q1 net triples to Rs 57 crGlenmark Pharmaceuticals’ net profit more than tripled to Rs 57.2 crore during the first quarter ended June 2007 on the back of overseas ac...
Load More
